Las Vegas – October 16, 2026 -- Rareview Capital LLC and Tuttle Capital Management have launched the Tuttle - Rareview Humanoid Robotics ETF (HOID), an actively managed fund that targets both humanoid robot developers and the technologies inside them.
HOID splits the robotics supply chain into "Brains" and "Body"
The strategy covers the "Brains": artificial intelligence, software and semiconductors. It also covers the "Body": sensors, actuators, batteries and other essential components. The fund extends beyond robot manufacturers to the suppliers behind them.
HOID may hold U.S. and international companies. These include firms in commercial production and those building fully functional prototypes that are moving toward commercialization. Portfolio weights are rebalanced at least quarterly.
Tuttle Capital acts as sub-adviser and co-portfolio manager
Matthew Tuttle, CEO of Tuttle Capital Management, is co-portfolio manager of HOID. He said the fund was built to follow the whole supply chain: "A humanoid robot has a brain and a body."
Neil Azous, Founder and Chief Investment Officer of Rareview Capital, expects meaningful advances in humanoid robotics over the next decade. He compared the field to the rapid evolution seen in artificial intelligence.
Prospectus flags China exposure, concentration and non-diversified structure
The fund may gain exposure to Chinese companies, including through China A-Shares and variable interest entities (VIEs). VIEs do not confer equity ownership in the underlying operating company.
HOID is concentrated in the industrials, information technology and consumer discretionary sectors. As a non-diversified fund, it may hold fewer securities than many peers, so a decline in one holding can weigh more heavily on its value. It may also invest in affiliated underlying funds, which creates conflicts of interest in asset allocation. The prospectus describes humanoid robotics companies as typically more volatile than less technology-reliant firms, with heavy research and development spending.